The influence of polymer topology on pharmacokinetics

Journal of Controlled Release

Volumn 140, Issue 3, 2009, Pages 185-

  Hennink, Wim ^a   Park, Kinam ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG CARRIER; POLYACRYLIC ACID; POLYMER;

AREA UNDER THE CURVE; CIRCULATION; COVALENT BOND; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG FORMULATION; DRUG TARGETING; EDITORIAL; HEMODYNAMICS; MOLECULAR WEIGHT; NANOPORE; PHARMACOKINETICS; PRIORITY JOURNAL; SOLID TUMOR; SOLUBILITY;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD CIRCULATION; EXCIPIENTS; MICE; MICE, INBRED BALB C; PHARMACOKINETICS; POLYMERS;

EID: 70449732069     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.10.019     Document Type: Editorial

References (1)

1. Chen B., Jerger K., Fréchet J.M., and Szoka F.C. The influence of polymer topology on pharmacokinetics: differences between cyclic and linear PEGylated poly(acrylic acid) comb polymers. J. Control. Release 140 (2009) 203-209